Kotaro Shirakawa
Kawahara, 6068507, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Correction to: Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy.
Journal: International journal of hematology
Published: June 25, 2026
Efficient discovery of an agonistic anti-OX40 nanobody by epitope-directed approach to address enrichment-driven epitope bias.
Journal: Journal for immunotherapy of cancer
Published: April 28, 2026
Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy.
Journal: International journal of hematology
Published: October 04, 2025
Low reticulocyte count at infusion is a risk factor for ICANS in CAR-T cell therapy.
Journal: Cytotherapy
Published: September 07, 2025
Recent advances in research of cure of HIV infection
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: September 03, 2025
APOBEC3B Does Not Promote Tumor Progression in Tp53 Hemizygous Mice.
Journal: Cancer reports (Hoboken, N.J.)
Published: September 27, 2024
Longitudinal analysis of genomic mutations in SARS-CoV-2 isolates from persistent COVID-19 patient.
Journal: iScience
Published: January 19, 2024
Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals.
Journal: The Lancet. Infectious diseases
Published: November 29, 2023
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
Journal: Journal of virology
Published: October 05, 2023
HTLV-1 bZIP factor impairs DNA mismatch repair system.
Journal: Biochemical and biophysical research communications
Published: February 28, 2023
The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant.
Journal: iScience
Published: August 25, 2022
Last Updated: 09/26/2026